<DOC>
	<DOCNO>NCT00687063</DOCNO>
	<brief_summary>The study conduct Asia . The aim observational study evaluate weight change baseline use Levemir® subject type 2 diabetes mellitus normal clinical practice condition India .</brief_summary>
	<brief_title>Observational Study Safety Efficacy Levemir® Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Any subject type 2 diabetes Subjects hypersensitivity insulin detemir excipient Children 6 year Subjects pregnant , lactate plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>